Target intelligence / Profile preview

Muskelin 1 (MKLN1)

Target
MKLN1
Molecular classification
Other (Scaffold protein), Component of the CTLH E3 ubiquitin-protein ligase complex, Kelch repeat family protein, Intracellular protein
01

Overview

Muskelin 1 (MKLN1) is an intracellular scaffold protein encoded by the MKLN1 gene on chromosome 7q32.3[1][2][5]. It is characterized by multiple conserved domains: N-terminal discoidin domain; LisH and CTLH alpha-helical domains; a kelch repeat β-propeller domain; and a C-terminal CRA domain[1]. Muskelin 1 is a component of the CTLH E3 ubiquitin-protein ligase complex, which submits specific substrate proteins for ubiquitination and degradation via the 26S proteasome, thereby regulating widespread cellular processes such as cell spreading, cytoskeletal dynamics, cell migration, and transcription factor turnover[1][2][7]. In neurons, muskelin 1 is required for internalization and degradation of the GABA receptor GABRA1 and can regulate its own levels by self-ubiquitination[2][7]. Although muskelin 1 is broadly expressed from embryogenesis to adulthood and regulates multiple protein networks in various tissues, genetic studies implicate it predominantly in neurological function and disorders[1][2]. There is no evidence of muskelin 1 being directly targeted by drugs nor used as a therapeutic biomarker in clinical practice.

Other names
Muskelin 1MuskelinMKLN1TWA2Intracellular mediator containing kelch motifs
02

Mechanism of action

Not applicable. There is no drug mechanism of action reported for muskelin 1 since no drugs target it[2][5][7].

03

Biological functions

Scaffold for CTLH E3 ubiquitin-protein ligase complex, facilitating ubiquitination and proteasomal degradationRegulates proteasomal degradation of several substrate proteins, including the transcription factor HBP1Mediates internalization and degradation of the GABA receptor GABRA1Mediates cell spreading, cytoskeletal and adhesion responses to extracellular matrix, especially thrombospondin IParticipant in cell migration, survival, proliferation, metabolism, adhesion, immune response, maternal–zygotic transition, autophagy, and erythropoiesis
04

Disease associations

Neurodevelopmental disorder: A muskelin SNP is linked with early-onset bipolar disorder (association known; mechanistic role unclear)Related pathways include those connected to Acrodermatitis and Lissencephaly, but direct causality is not established for muskelin 1Most clinical relevance is via its participation in the CTLH complex, notably for neurological conditionsNo high-confidence role in cancer, inflammation, or infection currently documented

Beyond the preview

Go deeper on Muskelin 1 (MKLN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muskelin 1 (MKLN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call